PROSTATE SPECIFIC ANTIGEN (PSA) FREE - ANVISA Registration 80048490017

Access comprehensive regulatory information for PROSTATE SPECIFIC ANTIGEN (PSA) FREE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490017 and manufactured by MONOBIND INC.. The registration is held by USA DIAGNOSTICA LTDA with validity until Nov 06, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, DIASORIN ITALIA S.P.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80048490017
2 Related Devices
Registration Details
ANVISA Registration Number: 80048490017
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

FREE PROSTATE SPECIFIC ANTIGEN (fPSA)
Risk Class III

Registration Details

80048490017

25351263639200649

02330159000108

Company Information

MONOBIND INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Nov 06, 2006

06/11/2026

09/18/2025 19:00:01

FREE PROSTATE SPECIFIC ANTIGEN (fPSA)
Risk Class III

Registration Details

80048490017

25351263639200649

02330159000108

Company Information

Dates and Status

Nov 06, 2006

06/11/2026

09/18/2025 19:00:01